Determining Tropism and Mechanisms of Ebola Virus Entry in Placental Tissues
确定埃博拉病毒进入胎盘组织的趋向性和机制
基本信息
- 批准号:10605584
- 负责人:
- 金额:$ 3.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-11-15 至 2025-07-14
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract
During pregnancy, viral infections in the mother may have catastrophic effects on her health, or on the
viability of the developing fetus. Recently, emerging pathogen outbreaks such as those involving Zika Virus
(ZIKV), SARS-CoV-2 or Ebola Virus (EBOV) have highlighted how understudied the role of the placenta is in
transmission of viral infections. This project specifically focuses on the cell tropism of EBOV during pregnancy.
Ebola Virus Disease (EVD) is caused by infection with EBOV or other members within the Ebolavirus genus.
During pregnancy, EVD results in loss of ~100% of fetuses or neonates with or without the additional loss of
the mother. Anecdotal data from EBOV outbreaks in Africa suggest that EBOV directly infects placental
tissues, thus transmitting virus to the fetal compartment, but rigorous experimental evaluation of placental
infection has not been performed; the tropism of EBOV for placental cells, mechanisms of cellular entry, and
route of infection from mother to fetus are currently unknown. Aim 1 will examine tropism of EBOV in placental
tissues. Further, as EBOV has been shown to bind to and internalize into many cell types via interactions with
phosphatidylserine (PS) receptors, Aim 2 studies will evaluate the role of three PS receptors on EBOV
infection of the placenta and fetus. These studies will be performed using two low containment EBOV model
viruses, rVSV-EBOV-GP-GFP and EBOV ΔVP30, that have been used extensively to understand filovirus
tropism and receptor usage. The knowledge gained from these rigorously designed studies will elucidate cell
populations within the placenta infected and important for fetal transmission as a first step toward
understanding the catastrophic pathogenesis of EVD in pregnancy. Additionally, this work will provide insights
for the development of therapeutic treatment options to improve the maternal and fetal outcomes of EVD.
The experiences, techniques, mentoring, and concepts in this proposal were specifically tailored to Ms.
Hanora Van Ert and her training goals. As a developing researcher passionate about improving the health and
wellbeing of pregnant women, Ms. Van Ert is currently completing her studies in the MSTP at University of
Iowa under the scientific mentorship of Dr. Wendy Maury and Dr. Mark Santillan receiving individualized
training at the intersection of virology, immunology, and reproductive health sciences to supply her passion
with the necessary research skills. Additionally, the MSTP, Department of OB/Gyn, and Department of
Microbiology and Immunology at the University of Iowa provide ample training opportunities in the forms of
seminar series, funding for attending academic conferences, opportunities to meet prominent people in the
fields of virology, immunology, and OB/Gyn, as well as a supportive and collaborative research environment.
Ms. Van Ert will complete her MSTP training and pursue a research residency in OB/Gyn, clinical Maternal-
fetal medicine fellowship, and ultimately tenure track position at an academic medical center to continue
investigating the host-pathogen immune response at the maternal-fetal interface within the placenta.
项目摘要/摘要
怀孕期间,母亲的病毒感染可能会对她的健康或对她的健康产生灾难性影响
发育中的胎儿的生存能力。最近,新兴的病原体暴发,例如涉及寨卡病毒的病原体
(ZIKV),SARS-COV-2或EBOLA病毒(EBOV)强调了Plopeta在
病毒感染的传播。该项目特别关注怀孕期间EBOV的细胞向性。
埃博拉病毒疾病(EVD)是由EBOV或埃博拉病毒属内其他成员感染引起的。
在怀孕期间,EVD导致约100%的胎儿或新生儿损失,或者没有额外的损失
母亲。非洲EBOV暴发的轶事数据表明,EBOV直接感染了PlaceAl
组织,从而将病毒传播到胎儿室,但对斑点的严格实验评估
尚未进行感染; EBOV用于占地细胞的向量,细胞进入机制和
目前尚不清楚从母亲到胎儿的感染途径。 AIM 1将检查EBOV的TROPISM
组织。此外,由于已显示EBOV通过与
磷脂酰丝氨酸(PS)受体,AIM 2研究将评估三个PS受体在EBOV上的作用
胎盘和胎儿的感染。这些研究将使用两个低遏制EBOV模型进行
病毒,RVSV-EBOV-GP-GFP和EBOVΔVP30,已广泛用于了解filevirus
向上主义和受体用法。从这些严格设计的研究中获得的知识将阐明细胞
胎盘中的种群感染了胎儿传播,这是迈向胎儿传播的第一步
了解怀孕中EVD的灾难性发病机理。此外,这项工作将提供见解
为了开发治疗方案,以改善EVD的产妇和胎儿结局。
该提案中的经验,技术,指导和概念是专门针对女士的。
Hanora van Ert及其训练目标。作为一名发展的研究人员,热衷于改善健康和
孕妇的健康,范·埃特(Van Ert)女士目前正在大学的MSTP学习
爱荷华州在温迪·莫里(Wendy Maury)和马克·桑蒂兰(Mark Santillan)博士的科学心态下接受个性化
在病毒学,免疫学和生殖健康科学的交叉点上培训,以供应她的激情
具有必要的研究技能。此外,MSTP,AB/GYN部和部门
爱荷华大学的微生物学和免疫学提供了充足的培训机会
研讨会系列,参加学术会议的资金,有机会结识杰出人士
病毒学,免疫学和ob/gyn领域,以及支持性和协作的研究环境。
Van Ert女士将完成她的MSTP培训,并在OB/Gyn购买研究住所
胎儿医学奖学金,并最终在学术医学中心任职
研究plapeta内母亲界界面处的宿主 - 病原体免疫反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
相似海外基金
UEM-Partnership for Research in Implementation Science Mozambique (PRISM).
UEM-莫桑比克实施科学研究伙伴关系(PRISM)。
- 批准号:1075577510755775
- 财政年份:2023
- 资助金额:$ 3.9万$ 3.9万
- 项目类别:
Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat)
范德比尔特-尼日利亚生物统计学培训计划(VN-BioStat)
- 批准号:1059454810594548
- 财政年份:2022
- 资助金额:$ 3.9万$ 3.9万
- 项目类别:
Molemolemo: Building Research Administration Excellence in South Africa
Molemolemo:在南非建立卓越的研究管理
- 批准号:1045814110458141
- 财政年份:2022
- 资助金额:$ 3.9万$ 3.9万
- 项目类别:
Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat)
范德比尔特-尼日利亚生物统计学培训计划(VN-BioStat)
- 批准号:1047051010470510
- 财政年份:2022
- 资助金额:$ 3.9万$ 3.9万
- 项目类别:
MEDSCAN: Mobile Enabled Diagnostics for Schistosomiasis Control Analytics
MEDSCAN:用于血吸虫病控制分析的移动诊断
- 批准号:1027994610279946
- 财政年份:2021
- 资助金额:$ 3.9万$ 3.9万
- 项目类别: